Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.67	75.05	93.12	203.43	288.64	181.38
Short-Term Investments	371.54	179.82	368.21	136.25	133.89	165.69
Cash & Short-Term Investments	403.21	254.87	461.33	339.68	422.53	347.07
Cash Growth	101.41%	-44.75%	35.81%	-19.61%	21.74%	-2.51%
Receivables	145.41	144.16	165.5	148.93	140.88	87.33
Inventory	63.98	77.41	91.54	85.96	48.33	26.63
Prepaid Expenses	27.4	16.68	15.78	27.02	18.68	11.61
Total Current Assets	640	493.11	734.15	601.59	630.42	472.64
Property, Plant & Equipment	37.96	42.52	44.08	52.32	58.06	38.35
Long-Term Investments	-	16.62	93.9	119.17	350.36	591.77
Goodwill	117.02	117.02	117.02	117.52	77.91	-
Other Intangible Assets	540.16	599.89	702.46	784.69	364.34	24.84
Long-Term Deferred Tax Assets	-	-	-	-	-	32.06
Other Long-Term Assets	7.56	8.51	10.9	13.87	23.02	0.62
Total Assets	1,343	1,278	1,703	1,689	1,504	1,160
Accounts Payable	6.39	1.96	10.54	9.33	6.15	10.14
Accrued Expenses	171.88	166.26	185.67	199.47	165.62	123.12
Current Portion of Long-Term Debt	-	-	407.97	7.24	5.32	3.24
Current Portion of Leases	9.23	8.33	6.79	6.48	7.52	2.83
Current Income Taxes Payable	-	-	-	-	-	2.44
Other Current Liabilities	104.01	113.64	76.99	92.86	60.5	18.82
Total Current Liabilities	291.51	290.2	687.96	315.38	245.11	160.59
Long-Term Debt	-	-	-	385.23	375.16	364.42
Long-Term Leases	28.93	33.2	36	41.3	48.81	30.44
Long-Term Deferred Tax Liabilities	7.36	24.96	49.81	85.36	35.22	-
Other Long-Term Liabilities	7.75	7.8	42.54	46.04	54.95	9.41
Total Liabilities	335.55	356.16	816.3	873.3	759.24	564.85
Common Stock	0.06	0.06	0.05	0.05	0.05	0.05
Additional Paid-In Capital	465.92	439.49	408.12	434.34	409.33	388.41
Retained Earnings	541.1	482.56	481.25	379.92	326.5	199.55
Comprehensive Income & Other	0.08	-0.59	-3.21	1.54	8.98	7.42
Shareholders' Equity	1,007	921.52	886.2	815.85	744.86	595.43
Total Liabilities & Equity	1,343	1,278	1,703	1,689	1,504	1,160
Total Debt	38.15	41.53	450.76	440.25	436.82	400.93
Net Cash (Debt)	365.06	229.96	104.47	18.6	336.08	537.92
Net Cash Growth	99.49%	120.12%	461.74%	-94.47%	-37.52%	27.89%
Net Cash Per Share	6.56	4.14	1.69	0.34	6.26	10.00
Filing Date Shares Outstanding	55.22	54.73	54.38	53.39	52.92	52.53
Total Common Shares Outstanding	55.22	54.72	54.25	53.26	52.87	52.53
Working Capital	348.5	202.92	46.19	286.21	385.31	312.06
Book Value Per Share	18.24	16.84	16.33	15.32	14.09	11.33
Tangible Book Value	349.98	204.61	66.72	-86.36	302.61	570.59
Tangible Book Value Per Share	6.34	3.74	1.23	-1.62	5.72	10.86
Machinery	14.21	14.03	13.11	14.23	14.64	12.89
Construction In Progress	-	-	0.21	0.03	-	0.43
Leasehold Improvements	14.02	14.02	14.02	14.37	15.18	14.22

Source: S&P Capital IQ. Standard template. Financial Sources.